Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
JEREMY B. HAYDEN Insider Profile
4 Followers
JEREMY B. HAYDEN, General Counsel & VP of BD at Plus Therapeutics, holds 168.62K shares in Sight Sciences (Ticker: SGHT), holds 32.04K shares in Endologix (Ticker: ELGXQ), holds 26.20K shares in Plus Therapeutics (Ticker: PSTV). Most recently, JEREMY B. HAYDEN Sold ― shares of Sight Sciences on Apr 04, 2024 for an estimated value of 24.81K.
JEREMY B. HAYDEN Plus Therapeutics (PSTV)General Counsel & VP of BD
Plus Therapeutics (PSTV)
General Counsel & VP of BD
Ranked #83,122 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-30.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that JEREMY B. HAYDEN holds in companies
Most Profitable Insider Trade
The most profitable trade made by JEREMY B. HAYDEN
JEREMY B. HAYDEN's Trading History
Plus Therapeutics
Sep 03, 2015
General Counsel & VP of BD
Informative Buy
2.87K
$45.59K
Endologix
Oct 07, 2019
―
Uninformative Buy
―
$608.76
Sight Sciences
Apr 04, 2024
CLO
Informative Sell
24.81K
$935.84K
List of latest transactions for each holding click on a transaction to see JEREMY B. HAYDEN's performance on stock
You May Also Like
JEREMY B. HAYDEN insider profile FAQ
What is the percentage of profitable transactions made by JEREMY B. HAYDEN?
The percentage of profitable transactions made by JEREMY B. HAYDEN is 25%.
What is the average return per transaction made by JEREMY B. HAYDEN?
The average return per transaction made by JEREMY B. HAYDEN is -30.50%.
What stocks does JEREMY B. HAYDEN hold?
JEREMY B. HAYDEN holds: PSTV, ELGXQ, SGHT stocks.
What was JEREMY B. HAYDEN’s latest transaction?
JEREMY B. HAYDEN latest transaction was an Informative Sell of $24.81K.
What was JEREMY B. HAYDEN's most profitable transaction?
JEREMY B. HAYDEN’s most profitable transaction was an Informative Sell of SGHT stock on April 4, 2024. The return on the trade was 5.30%.
What is JEREMY B. HAYDEN's role in Plus Therapeutics?
JEREMY B. HAYDEN's role in Plus Therapeutics is General Counsel & VP of BD.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.